Interlaboratory comparison of the CB6F1-Tg rasH2 rapid carcinogenicity testing model

Toxicology

Volumn 146, Issue 2-3, 2000, Pages 149-159

  Maronpot, R R ^a   Mitsumori, K ^b   Mann, P ^c   Takaoka, M ^d   Yamamoto, S ^e   Usui, T ^f   Okamiya, H ^g   Nishikawa, S ^h   Nomura, T ^f  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

^d DAIICHI SANKYO CO   (Japan)

^e KEIO UNIVERSITY   (Japan)

^f CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^g ASTELLAS PHARMA INC   (Japan)

^h KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Animal models; Cancer bioassays; Carcinogenicity; Hazard identification; Transgenic mice

Indexed keywords

ANILINE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CYCLOSPORIN A; MELPHALAN;

ANGIOSARCOMA; ANIMAL EXPERIMENT; ARTICLE; BLADDER TUMOR; CARCINOGENICITY; CARCINOMA; FEMALE; LUNG ADENOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ADENOMA; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; CARCINOMA; GENES, RAS; HEMANGIOSARCOMA; LABORATORIES; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; SPLENIC NEOPLASMS;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0034607676     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(00)00168-2     Document Type: Article

References (19)

1. Ando, K., Saitoh, A., Hino, O., Takahashi, R., Kimura, M., Katsuki, M., 1992. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes. Cancer Res. 52, 978-982.
2. Dahl, G., Miller, J., Miller, E., 1978. Vinyl carbamate as a promutagen and a more carcinogenic analog of ethyl carbamate. Cancer Res. 38, 3793-3804.
3. Doi, S.T., Kimura, M., Katsuki, M., 1994. Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice. Jpn. J. Cancer Res. 85, 801-807.
4. Eastin, W.C., Haseman, J.K., Mahler, J.F., Bucher, J.R., 1998. The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying carcinogens. Toxicol. Pathol. 26, 461-473.
5. Gart, J.J., 1970. Point and interval estimation of the common odds ratio in the combination of 2 × 2 tables with fixed marginals. Biometrika 57, 471-475.
6. Interagency Coordinating Committee on the Validation of Alternative Methods, 1997. Validation and Regulatory Acceptance of Toxicological Test Methods. NIH Publication No: 97-3981, National Institute of Environmental Health Sciences, Research Triangle Park, NC.
7. Lehmann, E.L., 1975. Nonparamatrics: Statistical Methods Based on Ranks. Holden-Day, San Francisco.
8. Massey, T.E., Stewart, R.K., Daniels, J.M., Liu, L., 1995. Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity. Proc. Soc. Exper. Biol. Med. 208, 213-227.
9. Mitsumori, K., Wakana, S., Yamamoto, S., Kodama, Y., Yasuhara, K., Nomura, T., Hayashi, Y., Maronpot, R., 1997. Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses on the induced tumors. Mol. Carcinog. 20, 298-307.
10. National Cancer Institute, 1978. Bioassay of p-Anisidine Hydrochloride for Possible Carcinogenicity. Technical Report Series No. 116. US Department of Health, Education, and Welfare, National Institutes of Health, Bethesda, MD.
11. National Cancer Institute, 1979. Bioassay of p-Cresidine for Possible Carcinogenicity. Technical Report Series No. 142. US Department of Health, Education, and Welfare, National Institutes of Health, Bethesda, MD.
12. National Research Council, 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
13. National Toxicology Program, 1992. Toxicology and Carcinogenesis Studies of Resorcinol in F344 Rats and B6C3F1 Mice (Gavage Studies). Technical Report Series No. 403. US Department of Health, Education, and Welfare, Public Health Service, Bethesda, MD.
14. Robinson, D., 1998. The International Life Sciences Institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk. Toxicol. Pathol. 26, 474-475.
15. Saitoh, A., Kimura, M., Takahashi, R., Yokoyama, M., Nomura, T., Izawa, M., Sekiya, T., Nishimura, S., Katsuki, M., 1990. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5, 1195-1200.
16. Society of Toxicologic Pathologists, 1998. Focus on: genetic altered mouse cancer models. Toxicol. Pathol. 26, 461-584.
17. Yamamoto, S., Mitsumori, K., Kodama, Y., Matsunuma, N., Manabe, S., Okamiya, H., Suzuki, H., Fukuda, T., Sakamaki, Y., Sunaga, M., Nomura, G., Hioki, K., Wakana, S., Nomura, T., Hayashi, Y., 1996. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harbouring human prototype c-Ha-ras gene than in control nontransgenic mice. Carcinogenesis 17, 2455-2461.
18. Yamamoto, S., Urano, K., Koizumi, H., Wakana, S., Hioki, K., Mitsumori, K., Kurokawa, K., Hayashi, Y., Nomura, T., 1998. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ. Health Perspect. 106, 57-69.
19. Zelen, M., 1971. The analysis of several 2 × 2 contingency tables. Biometrika 58, 129-137.